Media OutReach
Hong Kong Genome Institute and Global Leaders Co-organise Landmark Healthcare Event “International Genomic Medicine Symposium”
Convening Experts to Promote Hong Kong and Advance Medical Innovation
HONG KONG SAR – Media OutReach Newswire – 25 June 2025 – Genomic medicine is one of the most promising fields in today’s healthcare landscape, enabling precise diagnoses, personalised treatment plans, and breakthroughs in drug development that bring new hope to patients around the world. The Hong Kong Genome Institute (HKGI) will join forces with world-renowned authorities to host the International Genomic Medicine Symposium (Symposium) on 17 November 2025 (Monday). This landmark event will highlight Hong Kong’s unique strengths in fostering exchange and cooperation with experts worldwide in medical research and innovation, and accelerate the application of genomic medicine to pave the way for a healthier future for all.
The Symposium marks HKGI’s first collaboration with Rare Diseases International (RDI) and The Lancet Commission on Rare Diseases (LCRD), which is jointly led by RDI and The Lancet, the world’s most influential medical journal. The event will welcome local and international genomics leaders from over 20 countries and regions, including clinicians, scientists, and researchers from Mainland China, Europe, North and South America, and Australia.
Distinguished speakers at the Symposium will focus on key global topics such as clinical genetics, rare diseases, genomic medicine, AI, data sharing, as well as ethical and legal matters involved, facilitating in-depth discussions on the latest groundbreaking research and clinical insights. Specifically, thematic sessions will be dedicated to experience sharing by experts from Mainland China and Hong Kong. By showcasing case studies from the Hong Kong Genome Project, these exchanges will help demonstrate practical applications of personalised medicine in managing common disorders such as cardiomyopathy and kidney disease. Developments in rare diseases in Mainland China and drug development opportunities in the Guangdong-Hong Kong-Macao Greater Bay Area will also be covered, opening doors of opportunity for regional collaboration and innovation.
Dr Lo Su-vui, Chief Executive Officer of HKGI said, “With the strong support from the Health Bureau of the Hong Kong SAR Government, HKGI has been working closely with the Department of Health, Hospital Authority, medical schools of local universities and various stakeholders to accelerate the development of genomic medicine in Hong Kong. In just a few years, the Institute has achieved significant milestones in medical research, clinical applications, and international collaborations. We have successfully recruited over 47,000 participants for the Hong Kong Genome Project, continuously expanding our genome database featuring the Southern Chinese population. We have also accumulated clinical application cases and established synergistic collaborative research platforms. These achievements highlight Hong Kong’s strong capabilities and advantages in genomic medicine, laying a solid foundation for further collaboration with internationally recognised authorities.”
Dr Lo continued, “We are greatly honoured to partner with RDI and LCRD to organise this prestigious global event. Genomic medicine is the future of medicine with wide-ranging applications, spanning from common to rare diseases, from clinical diagnosis and personalised treatment to disease prevention and health management. This Symposium will undoubtedly serve as a critical platform for healthcare experts, academics, and researchers from around the world to exchange knowledge, fostering collaboration, and driving medical innovation, ultimately bringing immense benefits to patients in Hong Kong, Asia and beyond.”
The one-day Symposium is expected to attract nearly 300 industry professionals. Following the Symposium, the LCRD will hold its annual meeting in Hong Kong on 18-19 November to further discuss insights and deepen cross-regional collaboration. This will be the first time for the LCRD to host its annual meeting in Asia, highlighting Hong Kong’s distinctive position in leading international medical innovation.
For information about the Symposium programme and speakers, please refer to the appendix. For enquiries about the Symposium, please contact HKGI (sy*******@**********rg.hk) or RDI-LCRD (lc**@*************nt.org).
| Time | Programme | Speaker |
| 09:00 | Keynote | Prof Lo Chung-mau, BBS, JP Secretary for Health Hong Kong SAR Government, Hong Kong, China |
| 09:15 | Opening Ceremony | |
| Panel 1 | Session Chairperson: | Dr Ronald Lam, JP Director of Health Hong Kong SAR Government, Hong Kong, China |
| 09:30 | Developing Rare Disease Models in China: Service, Teaching and Research | Prof Zhang Shuyang President Peking Union Medical College Hospital, China |
| 10:00 | Unraveling Molecular Pathogeneses to Enhance Patient Care and Family Well-being | Prof Kym Boycott Co-Chair Lancet Commission on Rare Diseases Professor of Pediatrics University of Ottawa, Canada |
| 10:30 | Panel Discussion | |
| Panel 2 | Session Chairperson: | Dr Libby Lee, JP Under Secretary for Health Hong Kong SAR Government, Hong Kong, China |
| 11:15 | Insights into Rare Diseases: Focus on Inborn Errors of Metabolism |
Prof Roberto Giugliani Co-Chair Lancet Commission on Rare Diseases Professor of Genetics Federal University of Rio Grande do Sul, Brazil |
| 11:45 | Hong Kong Genome Project Case Sharing (1) – Unlocking the Genomics of Cardiomyopathy: A New Era in Heart Health | Dr Derek Lee Hong Kong College of Physicians – Hong Kong Genome Institute Scholar Hong Kong, China |
| 12:00 | Hong Kong Genome Project Case Sharing (2) – Precision Medicine in Nephrology | Dr Becky Ma Hong Kong Academy of Medicine – Hong Kong Genome Institute Scholar Hong Kong, China |
| 12:15 | Panel Discussion | |
| 12:30 | Lunch | |
| Panel 3 | Session Chairperson: | Prof Philip Chiu Dean of Medicine The Chinese University of Hong Kong, Hong Kong, China |
| 14:00 | Revolutionising Plasma DNA Analysis in Transforming Non-invasive Testing and Cancer Detection | Prof Dennis Lo, SBS, JP Vice-Chancellor and President The Chinese University of Hong Kong Board Member Hong Kong Genome Institute Hong Kong, China |
| 14:30 | Publishing at The Lancet | Dr Chloe Wilson Senior Medical Editor The Lancet |
| 15:00 | Panel Discussion | |
| Panel 4 | Session Chairperson: | Prof Lau Chak-sing, BBS, JP Vice-President & Pro-Vice-Chancellor (Health) Dean of Medicine The University of Hong Kong Board Member Hong Kong Genome Institute Hong Kong, China |
| 15:35 | AI in Action: The Journey from Clinical Record to Personalised Treatment |
Prof Gareth Baynam Medical Director Rare Care Centre Perth Children’s Hospital, Australia |
| 16:05 | Harnessing the Power of Electronic Healthcare Records in Scientific Research and Innovation in Genomic Medicine | Prof Yong Chen Professor of Biostatistics University of Pennsylvania, USA |
| 16:35 | Panel Discussion | |
| Panel 5 | Session Chairperson: | To be confirmed |
| 16:50 | The Health Rights of Children and Genomic Newborn Screening | Prof Bartha Knoppers Director Centre of Genomics and Policy McGill University, Canada |
| 17:20 | Hong Kong Genome Project: Advancing the Genomics Frontier |
Dr Brian Chung Chief Medical and Scientific Officer Hong Kong Genome Institute, Hong Kong, China |
| 17:40 | Genomics as a Catalyst for Drug Development in the Greater Bay Area |
Prof Aya El Helali Clinical Assistant Professor Department of Clinical Oncology, School of Clinical Medicine, The Li Ka Shing Faculty of Medicine of the University of Hong Kong, Hong Kong, China |
| 18:00 | Panel Discussion | |
| 18:15 | End of Symposium | |
Hong Kong Genome Institute
Website: www.hkgp.org
Email: sy*******@**********rg.hk
Rare Disease International
Website: www.rarediseasesinternational.org
Email: lc**@*************nt.org
Hashtag: #HongKongGenomeInstitute
The issuer is solely responsible for the content of this announcement.
About Hong Kong Genome Institute
The Hong Kong Genome Institute (HKGI), established and wholly owned by the Hong Kong SAR Government, commenced full operations in 2021. With the vision “to avail genomic medicine to all for better health and well-being” and supported by the Health Bureau, HKGI works in close collaboration with the Department of Health, Hospital Authority, medical schools of local universities and other stakeholders to accelerate the development of genomic medicine in Hong Kong along four strategic foci: integrate genomics into medicine, advance research, nurture talents and enhance public genomic literacy.
As the first step towards achieving its vision, HKGI launched the Hong Kong Genome Project (HKGP) in 2021 focusing on diseases and research cohorts that would benefit from whole genome sequencing. They include undiagnosed diseases, hereditary cancers and cases related to genomics and precision health. Being the city’s first large-scale genome sequencing project, HKGP serves as a catalyst to benefit patients and their families with more precise diagnosis and personalised treatment. It also aims to establish genome database of the local population, testing infrastructure and talent pool to address the healthcare needs of Hong Kong in the long run.
For more information, please visit 
https://hkgp.org/en.
About Rare Diseases International
Rare Diseases International (RDI) is the global alliance of people living with a rare disease of all nationalities across all rare diseases. RDI’s mission is to be a strong common voice on behalf of rare disease patients around the world, to advocate for rare diseases as an international public health priority and to represent its members and enhance their capacities. RDI has more than 120 member organizations from 50 countries, which in turn represent rare disease patient groups in more than 150 countries worldwide.
For more information, please visit https://www.rarediseasesinternational.org.
About Lancet Commission on Rare Diseases
The RDI-Lancet Commission on Rare Diseases (RDI-LCRD) is a new initiative dedicated to improving the lives of Persons Living with a Rare Disease (PLWRD) globally by generating evidence-informed recommendations that can be implemented in all countries. The RDI-LCRD, chaired by Dr Roberto Giugliani (Brazil) and Dr Kym Boycott (Canada) brings together 27 Commissioners from 6 continents with a broad range of expertise, perspectives and experience. The overarching goal of the RDI-LCRD is to use robust data to ignite global action that will amplify the voices of PLWRD and ensure that they are seen, heard, and cared for, no matter where they live.
For more information, please visit http://www.rarediseasescommission.org.
The Reality of the Raya Rush
The lead-up to Raya is a whirlwind of grocery runs, deep cleaning, and late nights in the kitchen. By the time the first open house begins, most women have already put in an incredible amount of effort for their families. The quiet moments in between are not just a break. They are earned.
XIXILI’s pajamas are made for those moments. Easy to move in, soft enough to wear through the night, and the kind of pieces that make coming home feel like something to look forward to. Designed to fit a wide range of body types, every woman can find something that feels as good as it looks.
“Raya is everything. The food, the family, the laughter. And at the end of it all, she deserves to rest just as well as she celebrated,” says Tara Tan, Marketing Director at XIXILI.
Comfort That Carries Through the Season
Raya may bring the occasion, but the shift happening in Malaysian wardrobes goes further than that. Women are increasingly treating sleepwear as a considered part of their self-care, not just something to change into before bed.
“We often talk about the joy of gathering, but we rarely talk about the exhaustion that comes with it,” Tara Tan adds. “Our goal for Raya 2026 is to ensure that when the last guest leaves, every woman has a high-quality piece of loungewear to retreat into. It is about honouring the work she does by giving her the rest she deserves.”
Quality loungewear for the wind-down, the slow morning, and every quiet moment in between has become one of the most considered purchases a woman makes this season.
Made to Be Worn, Not Just Owned
Good sleepwear should not sit tucked away at the back of a drawer. It should be the first thing she reaches for at the end of a long day, worn in and looked forward to. XIXILI’s range is built for exactly that, styles that settle naturally into her routine and carry her well beyond the festive season.
The full sleepwear collection is available online and at XIXILI boutiques nationwide. To shop the range, visit www.xixili-intimates.com.Hashtag: #XIXILI
https://www.xixili-intimates.com/my/
https://www.facebook.com/XIXILI.OfficialFanPage/
https://www.instagram.com/xixili_intima/
https://www.tiktok.com/@xixili_intima?
https://www.youtube.com/user/xixilipage
The issuer is solely responsible for the content of this announcement.
About XIXILI
A homegrown Malaysian brand, XIXILI offers beautiful fashion lingerie and shapewear in Malaysia that prioritises fit and comfort. With an extensive range of bra sizes from A to I and bands 65 to 110cm, XIXILI caters to women of all shapes and sizes. Expert fitters are dedicated to helping each customer find the perfect bra, boosting confidence and enhancing silhouettes.
XIXILI became the first Malaysian lingerie brand to introduce a Try-On in 3D avatar tool, allowing customers to virtually try on XIXILI lingerie using a 3D avatar tailored to their specific body type and measurements. Whether for everyday wear or something special, XIXILI ensures women always look and feel amazing.
Specifically, in addition to the existing incentives currently available, customers who switch from old gasoline vehicles to new VinFast electric vehicles during the program period will receive an additional 3% discount for cars and 5% discount for scooters. The program will be applied across all four markets: Vietnam, India, Indonesia, and the Philippines.
In line with VinFast’s pioneering spirit, GSM Green and Smart Mobility Joint Stock Company has also announced an immediate 10% reduction in fares for electric mobility services on the Xanh SM platform in Vietnam and Green SM in Indonesia from March 11 to March 31, 2026. This initiative offers customers a more environmentally-friendly and cost-effective transportation option.
The program may be extended depending on international developments and future fuel price movements.
Ms. Duong Thi Thu Trang, Deputy CEO of Global Sales, VinFast, stated: “The special ‘Trade Gas for Electric’ program launched in March across four key markets is VinFast’s timely response to geopolitical volatility that is affecting socio-economic conditions in many countries around the world. As one of the pioneering manufacturers leading the global electric vehicle revolution, VinFast together with companies in Vingroup’s green ecosystem aims to help reduce the impact of fuel prices on people’s daily lives while also lowering environmental pollution through smarter, more sustainable, and more cost-efficient mobility solutions.”
The special “Trade Gas for Electric” program will be implemented in parallel with and combined with other available incentive programs in each market. Through layered incentives, Vingroup and companies within its ecosystem aim to create favorable conditions for customers to transition quickly to electric vehicles, reduce dependence on gasoline, stabilize daily life, and contribute to building a cleaner and more civilized living environment.
Hashtag: #Vingroup
The issuer is solely responsible for the content of this announcement.
Media OutReach
Singapore University of Social Sciences Expands Regional Footprint in China with Launch of Success Academy in Chongqing
New Academy and Shenyang satellite office strengthen SUSS’ visibility and partnerships across Western and Northeast China.
CHONGQING, CHINA – Media OutReach Newswire – 10 March 2026 – The Singapore University of Social Sciences (SUSS) today launched the SUSS Success Academy in Chongqing in collaboration with Raffles Young Academy (RYA) Pte Ltd and announced the establishment of a satellite office in Shenyang. Building on its Success Academies in Beijing and Shenzhen, the Academy strengthens SUSS’ presence in China and supports its growing engagement across Western and Northeast China.
The launch was commemorated with an opening ceremony at the CCI Gallery, attended by close to 70 guests from China and Singapore, including representatives from institutions of higher learning, and industry and community partners. The ceremony was presided by Vice-Consul (Political) Ms. Mavis Tan, Consulate-General of the Republic of Singapore, Chengdu and Mr. Li Xunfu, Deputy Director of Chongqing Municipal Commission of Commerce.
Success Academy to connect partners from Singapore and China
Anchored in SUSS’ commitment to lifelong learning and creating social impact, the Academy will serve as a key nexus for academic and industry partners from both countries. Through cross-cultural collaboration and practice-oriented learning, it also aims to develop future-ready talent equipped to contribute meaningfully to society and the economy.
RYA is an education and talent development organisation aimed at nurturing future-ready talent through industry-oriented learning and international exposure. RYA will bring its networks and local expertise to support and enhance the Academy’s initiatives.
Through the Academy, SUSS will provide opportunities for students from SUSS and other Singapore pre-tertiary and tertiary institutions to co-learn and co-innovate with peers in China. These include interdisciplinary global learning courses, impact startup and venture builder programmes, industry-based immersions and student exchanges. SUSS students will also gain regional exposure through internships and other workplace learning opportunities. In addition, the Academy will support SUSS in working with universities and organisations in China to jointly design and deliver industry-relevant courses and programmes for students and executives.
Extending engagement into Northeast China with Shenyang satellite office
To further deepen its engagement in Northeast China, SUSS will launch a satellite office in Shenyang on 11 March 2026 under the Success Academy in Chongqing. This office will support SUSS’ initiatives in Liaoning Province and surrounding areas, including Dalian. In addition, three Memoranda of Understanding (MOU) will be signed with the following organisations:
- Shenyang University of Chemical Technology (SYUCT): Collaborative development of a Master’s degree programme in Social Work, fostering cross-border knowledge exchange, curriculum innovation, and talent development to address evolving social service needs.
- North-East Institute of Population and Social Development: Joint research endeavours, professional development programmes, and meaningful academia-industry partnerships to generate evidence-based solutions, build capabilities, and promote active ageing ecosystems that benefit individuals and communities.
Professor Tan Tai Yong, President of SUSS, said, “China is an important partner for SUSS as we expand opportunities for our students and strengthen collaboration across Asia. The launch of the Success Academy in Chongqing allows us to work more closely with universities, industry and community partners in Western and Northeast China, and to deliver applied, practice-oriented education that responds to real-world needs. Our partnership with Raffles Young Academy reflects our shared commitment to developing future-ready talent and supporting professional growth across the region.”
Mr. Samuel Ng, Executive Chairman, RYA, said, “Our collaboration with the Singapore University of Social Sciences reflects a shared belief in applied, practice-oriented education and in preparing students and enterprises to navigate an increasingly complex and interconnected world. Chongqing’s strategic position as a gateway to Western China and a hub for industry and connectivity makes it an ideal location for immersive, industry-linked education. This partnership represents a long-term commitment to building enduring bridges between students and industry, between academia and practice, and between Singapore and China.”
The launch of the Success Academy in Chongqing is part of SUSS’ broader expansion across Asia. Since 2023, SUSS has established Success Academies in Beijing, Shenzhen, Ho Chi Minh City Bangkok, Kuala Lumpur, Jakarta, Manila and Mumbai.
For more information, visit www.suss.edu.sg/success-academy.
Hashtag: #SUSS
https://www.suss.edu.sg
https://www.linkedin.com/school/singapore-university-of-social-sciences
https://www.facebook.com/suss.sg
https://www.instagram.com/suss.sg
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn